title: A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy.
abstract: The parametric response map (PRM) was evaluated as an early surrogate biomarker for monitoring treatment-induced tissue alterations in patients with head and neck squamous cell carcinoma (HNSCC). Diffusion-weighted magnetic resonance imaging (DW-MRI) was performed on 15 patients with HNSCC at baseline and 3 weeks after treatment initiation of a nonsurgical organ preservation therapy (NSOPT) using concurrent radiation and chemotherapy. PRM was applied on serial apparent diffusion coefficient (ADC) maps that were spatially aligned using a deformable image registration algorithm to measure the tumor volume exhibiting significant changes in ADC (PRM(ADC)). Pretherapy and midtherapy ADC maps, quantified from the DWIs, were analyzed by monitoring the percent change in whole-tumor mean ADC and the PRM metric. The prognostic values of percentage change in tumor volume and mean ADC and PRM(ADC) as a treatment response biomarker were assessed by correlating with tumor control at 6 months. Pixel-wise differences as part of PRM(ADC) analysis revealed regions where water mobility increased. Analysis of the tumor ADC histograms also showed increases in mean ADC as early as 3 weeks into therapy in patients with a favorable outcome. Nevertheless, the percentage change in mean ADC was found to not correlate with tumor control at 6 months. In contrast, significant differences in PRM(ADC) and percentage change in tumor volume were observed between patients with pathologically different outcomes. Observations from this study have found that diffusion MRI, when assessed by PRM(ADC), has the potential to provide both prognostic and spatial information during NSOPT of head and neck cancer.
authors.affiliation: The University of Michigan Medical School, Ann Arbor, MI, USA.
authors.forename: Craig J
authors.initials: CJ
authors.lastname: Galbán
authors.forename: Suresh K
authors.initials: SK
authors.lastname: Mukherji
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Chenevert
authors.forename: Charles R
authors.initials: CR
authors.lastname: Meyer
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hamstra
authors.forename: Peyton H
authors.initials: PH
authors.lastname: Bland
authors.forename: Timothy D
authors.initials: TD
authors.lastname: Johnson
authors.forename: Bradford A
authors.initials: BA
authors.lastname: Moffat
authors.forename: Alnawaz
authors.initials: A
authors.lastname: Rehemtulla
authors.forename: Avraham
authors.initials: A
authors.lastname: Eisbruch
authors.forename: Brian D
authors.initials: BD
authors.lastname: Ross
references.citation: J Clin Oncol. 2008 Jul 10;26(20):3387-94
references.pmid: 18541899
references.citation: Transl Oncol. 2008 Dec;1(4):187-94
references.pmid: 19043529
references.citation: Clin Cancer Res. 2009 Feb 1;15(3):986-94
references.pmid: 19188170
references.citation: Acta Radiol. 2008 Nov;49(9):1079-84
references.pmid: 18785024
references.citation: Neoplasia. 2007 Dec;9(12):1160-5
references.pmid: 18084623
references.citation: Neoplasia. 2009 Mar;11(3):237-46, 1p following 246
references.pmid: 19242605
references.citation: Neoplasia. 2009 Mar;11(3):247-59, 2p following 259
references.pmid: 19242606
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Neoplasia. 2009 Jun;11(6):574-82, 1 p following 582
references.pmid: 19484146
references.citation: Mol Ther. 2004 Nov;10(5):916-28
references.pmid: 15509509
references.citation: Nat Med. 2009 May;15(5):572-6
references.pmid: 19377487
references.citation: Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):958-65
references.pmid: 12829130
references.citation: Med Image Anal. 1997 Apr;1(3):195-206
references.pmid: 9873906
references.citation: Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16759-64
references.pmid: 16267128
references.citation: Neoplasia. 2009 Feb;11(2):102-25
references.pmid: 19186405
references.citation: NMR Biomed. 1995 Nov-Dec;8(7-8):289-96
references.pmid: 8739267
references.citation: J Clin Oncol. 2007 Sep 10;25(26):4104-9
references.pmid: 17827460
references.citation: AJNR Am J Neuroradiol. 2008 Jan;29(1):40-4
references.pmid: 17921228
references.citation: Neoplasia. 2007 May;9(5):392-400
references.pmid: 17534444
references.citation: Magn Reson Med. 1999 Nov;42(5):952-62
references.pmid: 10542355
references.citation: Neoplasia. 2007 Dec;9(12):1003-11
references.pmid: 18084607
references.citation: J Natl Cancer Inst. 2000 Dec 20;92(24):2029-36
references.pmid: 11121466
references.citation: Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):960-71
references.pmid: 17141979
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5524-9
references.pmid: 15805192
references.citation: Neoplasia. 2006 Apr;8(4):259-67
references.pmid: 16756718
references.citation: Strahlenther Onkol. 2003 Sep;179(9):641-9
references.pmid: 14628131
references.citation: Clin Cancer Res. 1997 Sep;3(9):1457-66
references.pmid: 9815831
references.citation: Radiology. 2001 Sep;220(3):621-30
references.pmid: 11526259
references.citation: Curr Opin Oncol. 2006 May;18(3):234-9
references.pmid: 16552234
references.citation: Neoplasia. 2004 Nov-Dec;6(6):831-7
references.pmid: 15720810
references.citation: J Clin Oncol. 2003 Mar 15;21(6):1094-100
references.pmid: 12637476